Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients

NCT06315842 · tracked via the Priya Life Science Spain tracker

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Phase

Not applicable

Started

2026-02

Last updated

2025-12-05

Condition(s) studied

Acute Disease

Investigational drug(s) / intervention(s)

Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.Usual clinical practice

Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.: During the intervention periods, participating physicians will integrate into their usual clinical practice a tool for adjusting diagnostic and therapeutic intensity designed by Fontecha-Gómez and colleagues. The tool for adjusting the level of diagnostic and therapeutic intensity classifies patients' profiles into 5 groups based on the recommended level of adjustment.

Usual clinical practice: The participating physicians will carry out the standard clinical practice currently performed in the study centers. This means that during this period, the diagnostic and therapeutic adjustment tool or any similar tool will not be introduced into routine clinical practice.

Study summary

The objective of this clinical trial is to investigate the impact of implementing a tool for adjusting the level of diagnostic and therapeutic intensity in the clinical practice of physicians attending hospitalized patients.

The goal of this clinical trial is to investigate the impact of a tool for adjusting diagnostic and therapeutic intensity in hospitalized patients. The main question it aims to answer is: Is there a difference in patient mortality when using the aforementioned tool? The participating physicians will be grouped into 4 groups (5 physicians each). Each group will progressively (every 3 months) incorporate the use of the aforementioned tool into their usual clinical practice.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Physician belonging to the non-surgical medical area. * Routine clinical activity on a hospital ward caring for hospitalized patients. Exclusion Criteria: * Physician belonging to the Oncology-Hematology/Palliative Care Hospitalization Unit. * Refusal to participate in the study.

Primary outcome measure(s)

In-hospital Patient Mortality at 90 days from hospital discharge — 90 days from hospital discharge
Percentage of patients who die during hospitalization until 90 days from hospital discharge.

Trial sites (1)

Facility	City	Region	Status
Consorci Sanitari Alt Penedes i Garraf	Vilafranca del Penedès	Barcelona

More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study Active, not recruiting

Predictive Model for Mortality in Older People With Critical Illness Recruiting

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach Recruiting

Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults Starting soon

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality Recruiting

Other trials for the same condition

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality Recruiting

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06315842 on ClinicalTrials.gov ↗ ← All trials in Spain